Join to View Full Profile
4500 Eldorado Pkwy.Suite 3400McKinney, TX 75070
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Douglas Porter, MD is a board certified neurologist in McKinney, Texas. He is currently licensed to practice medicine in Texas, Minnesota, and Idaho. He is affiliated with Intermountain Health Lutheran Hospital, Intermountain Health Saint Joseph Hospital, and Intermountain Health St. Mary's Regional Hospital.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Clinical Neurophysiology, 2012 - 2013
MedStar Health Georgetown UniversityResidency, Neurology, 2009 - 2012
UMass Chan - BaystateInternship, Internal Medicine, 2008 - 2009
Tufts University School of MedicineClass of 2008
Certifications & Licensure
MI State Medical License 2015 - 2028
SC State Medical License 2014 - 2027
NJ State Medical License 2016 - 2027
NM State Medical License 2014 - 2027
NV State Medical License 2014 - 2027
ME State Medical License 2018 - 2027
MD State Medical License 2019 - 2027
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsDysregulation of the mesolimbic dopamine system and reward in MCH-/- micePavlos Pissios, Lauren E. Frank, Adam R. Kennedy, Douglas R. Porter, Francis E. Marino
Biological Psychiatry. 2008-08-01 - 418 citationsImpaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient miceTohru Kitada, Antonio Pisani, Douglas R. Porter, Hiroo Yamaguchi, Anne Tscherter
Proceedings of the National Academy of Sciences of the United States of America. 2007-07-03 - 154 citationsDJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor.Nan Zhong, Christina Y. Kim, Patrizia Rizzu, Changiz Geula, Douglas R. Porter
The Journal of Biological Chemistry. 2006-07-28
